Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia. [electronic resource]
Producer: 20160427Description: 1636-43 p. digitalISSN:- 1556-3871
- Adolescent
- Adrenergic beta-Antagonists -- therapeutic use
- Adult
- Child
- Death, Sudden, Cardiac -- etiology
- Defibrillators, Implantable
- Electrocardiography, Ambulatory -- methods
- Exercise Test -- methods
- Female
- Genetic Predisposition to Disease
- Genetic Testing -- methods
- Humans
- Male
- Middle Aged
- Mutation
- Pedigree
- Risk Assessment
- Ryanodine Receptor Calcium Release Channel -- genetics
- Spain
- Tachycardia, Ventricular -- complications
- Treatment Outcome
- Polymorphic Catecholaminergic Ventricular Tachycardia
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.